2022
DOI: 10.1038/s41421-022-00412-3
|View full text |Cite
|
Sign up to set email alerts
|

Structural insights into the ligand binding and Gi coupling of serotonin receptor 5-HT5A

Abstract: Abstract5-hydroxytryptamine receptor 5A (5-HT5A) belongs to the 5-HT receptor family and signals through the Gi/o protein. It is involved in nervous system regulation and an attractive target for the treatment of psychosis, depression, schizophrenia, and neuropathic pain. 5-HT5A is the only Gi/o-coupled 5-HT receptor subtype lacking a high-resolution structure, which hampers the mechanistic understanding of ligand binding and Gi/o coupling for 5-HT5A. Here we report a cryo-electron microscopy structure of the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(5 citation statements)
references
References 43 publications
0
5
0
Order By: Relevance
“…Notably, replacement with the polar residue threonine appeared to differentially impact the efficacies of setiptiline and mianserin (Emax = 51.2% and 78.3% of 5-HT, respectively), in line with the suggestion of different ligand-receptor interactions from our SIFt analysis. E311 6.55 shows different conformations in the mianserin-and setiptiline-bound structures and previous studies have highlighted the importance of interactions with residues at position 6.55 for ligand specificity (39). According to the SIFt analysis, E311 6.55 forms highly probable apolar interactions with both mianserin and setiptiline during simulation, but it forms an electrostatic interaction with mianserin only, albeit with a very low probability (Fig.…”
Section: Probing Distinct 5-ht1er Binding Pose Of Tetracyclic Antidep...mentioning
confidence: 51%
“…Notably, replacement with the polar residue threonine appeared to differentially impact the efficacies of setiptiline and mianserin (Emax = 51.2% and 78.3% of 5-HT, respectively), in line with the suggestion of different ligand-receptor interactions from our SIFt analysis. E311 6.55 shows different conformations in the mianserin-and setiptiline-bound structures and previous studies have highlighted the importance of interactions with residues at position 6.55 for ligand specificity (39). According to the SIFt analysis, E311 6.55 forms highly probable apolar interactions with both mianserin and setiptiline during simulation, but it forms an electrostatic interaction with mianserin only, albeit with a very low probability (Fig.…”
Section: Probing Distinct 5-ht1er Binding Pose Of Tetracyclic Antidep...mentioning
confidence: 51%
“…E311 6.55 shows different conformations in the mianserin- and setiptiline-bound structures, and previous studies have highlighted the importance of interactions with residues at position 6.55 for ligand specificity ( 39 ). According to the SIFt analysis, E311 6.55 forms highly probable apolar interactions with both mianserin and setiptiline during simulation, but it forms an electrostatic interaction with mianserin only, albeit with a very low probability ( Fig.…”
Section: Resultsmentioning
confidence: 82%
“…The X-ray crystal structure (PDB ID: 5U5L) of PPAR-γ in complex with rivoglitazone was resolved to 2.55 Å [10]. Similarly, the X-ray crystal structures of both serotonin receptors, namely 5-HT 1A (PDB ID: 7E2Y) and 5-HT 2A (PDB ID: 6A93), bound with serotonin and risperidone, respectively, were resolved to 3.00 Å [45,46].…”
Section: Molecular Dockingmentioning
confidence: 95%